SCHEMBL6029667

SCHEMBL6029667

CCCCCCCCOC(=O)Nc1scc(CCCCCC)c1C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
EPHX1 P07099 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 1/20 0.38
TSHR P16473 4/20 0.38
MAPK1 P28482 3/20 0.38
MAPT P10636 2/20 0.38
HSD17B10 Q99714 1/20 0.38
CSNK2A2 P19784 2/20 0.37
CSNK2A1 P68400 2/20 0.37
MMP1 P03956 1/20 0.37
MMP9 P14780 1/20 0.37
MMP12 P39900 1/20 0.37
NPC1 O15118 1/20 0.37
CASP1 P29466 1/20 0.37
RAB9A P51151 1/20 0.37
GAA P10253 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6030618 0.85 CSNK2A2 (0.45) ALDH1A1EPHX1L3MBTL1TSHRMAPK1
SCHEMBL6031468 0.82 L3MBTL1 (0.35) ALDH1A1EPHX1L3MBTL1TSHRMAPK1
SCHEMBL6206821 0.81 MEN1 (0.52) ALDH1A1EPHX1L3MBTL1MEN1KMT2A
SCHEMBL6030337 0.79 CNR1 (0.44) ALDH1A1EPHX1TSHRMAPK1MAPT
SCHEMBL6030952 0.79 CNR1 (0.44) ALDH1A1EPHX1TSHRMAPK1MAPT
SCHEMBL6030817 0.78 HSD17B10 (0.55) ALDH1A1EPHX1L3MBTL1MEN1KMT2A
SCHEMBL6030807 0.78 HSD17B10 (0.55) ALDH1A1EPHX1L3MBTL1MEN1KMT2A
SCHEMBL6031371 0.78 HSD17B10 (0.55) ALDH1A1EPHX1L3MBTL1MEN1KMT2A
SCHEMBL6031127 0.78 HSD17B10 (0.55) ALDH1A1EPHX1L3MBTL1MEN1KMT2A
SCHEMBL6029945 0.78 HSD17B10 (0.55) ALDH1A1EPHX1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7064122-B2 Pancreatic lipase inhibitor compounds, their synthesis and use OSI PHARMACEUTICALS, INC. (US) 2006-06-20 US disclosed
US-20030195199-A1 Pancreatic lipase inhibitor compounds, their synthesis and use OSI PHARMACEUTICALS, INC. 2003-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195199-A1 Pancreatic lipase inhibitor compounds, their synthesis and use PNLIP, LIPC, CEL ALDH1A1 1832/4885EPHX1 938/4885L3MBTL1 1266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.